seed
Stage
2012
Founded
1
Investors
About
NunaBio is a next-generation CDMO and full‑stack synthetic DNA platform that provides cell‑free enzymatic synthesis, assembly and amplification of high-fidelity, endotoxin-free DNA in multiple formats and at gram-scale in days. The company targets biotech, pharma and government partners and offers distributed micro‑foundry deployment and custom DNA products (minicircles, modified DNA, long/complex constructs).
Explore NunaBio - company's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.